• Routine genomic screening could help identify otherwise undetected cancer risk

    30 days ago - By Healio

    Most carriers of genetic mutations known to increase the risk for breast, ovarian, prostate and pancreatic cancers appeared unaware of their mutation carrier status despite frequent interactions with the health care system, according to results of a cross-sectional study published in JAMA Network Open.
    Exome sequencing-based screening may help identify BRCA1- and BRCA2-associated cancer risk that otherwise might go undetected within health care systems, results showed.
    “As a colleague said, it usually takes a tragedy for people to get tested,” Michael Murray, MD, professor of
    Read more ...